

Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.
You can purchase shares of Microbot Medical (NASDAQ:MBOT) through any online brokerage.
Other companies in Microbot Medical’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Microbot Medical has a consensus price target of $5.60.
The stock price for Microbot Medical (NASDAQ: MBOT) is $1.11 last updated November 11, 2026 at 6:17 PM EST.
There are no upcoming dividends for Microbot Medical.
Microbot Medical does not have any upcoming earnings scheduled.
There is no upcoming split for Microbot Medical.
Microbot Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform,...